Abdallah Marey Aboshhran (2023) “PUBLIC INTEREST IN THE OFF-LABEL USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (OZEMPIC) FOR COSMETIC WEIGHT LOSS‏”, Journal of Population Therapeutics and Clinical Pharmacology, 30(2), pp. 745–747. doi:10.53555/jptcp.v30i2.4746.